Inozyme Pharma
AcquiredPioneering therapies for rare diseases of abnormal mineralization.
Inozyme Pharma was founded in 2017, is headquartered in Cambridge, United States, lists 11–50 employees, and has 2 recorded funding rounds.
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- inozyme.com
- Last Round
- Series AApr 2019
- Rounds
- 2
- Acquired by
- BioMarin Pharmaceutical Inc.May 2025
Indexed holds 2 funding rounds and 10 investors for this company. The full record is or through the API.
About
Inozyme Pharma, founded in 2017 and headquartered in Boston, Massachusetts, was a pioneering clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for rare diseases characterized by abnormal mineralization. The company's lead program, INDEE, targeted ENPP1 deficiency, a life-threatening rare disease affecting the heart, vasculature, and skeleton. With approximately 50 employees, Inozyme went public on Nasdaq (INZY) before being acquired by BioMarin Pharmaceutical in May 2025 for $270 million.
Summary
Inozyme Pharma is a Biotech company based in Cambridge, United States, founded in 2017. It lists 11–50 employees. Its most recent funding was a Series A round in Apr 2019. Investors include BioMarin Pharmaceutical, Pivotal bioVenture Partners and Sofinnova Investments.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
May 2025
Sign up to see all 3 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
BioMarin Pharmaceutical
1 round
Pivotal bioVenture Partners
1 round
Sofinnova Investments
1 round
Longitude Capital
1 round
RA Capital Management
1 round
Cowen Healthcare Investments
1 round
Rock Springs Capital
1 round
New Enterprise Associates
1 round
Sanofi Ventures
1 round
Novo Holdings A/S
1 round
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/inozyme-pharma"><img src="https://indexed.vc/api/badge/company/inozyme-pharma" alt="Inozyme Pharma on Indexed.vc" width="260" height="76" /></a>